Crossmark

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s40478-017-0505-x

Published Online: 2018-01-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moro, Maria Luisa

Phillips, Andrew Stephen

Gaimster, Katie

Paul, Christian

Mudher, Amritpal

Nicoll, James A. R.

Boche, Delphine
Funding

Funding for this research was provided by:

Marie Curie Intra European Fellowship within the 7th European Community Framework (Project No: 627152; Project Acronym: AlzProtAgeing)

Alzheimer’s Research UK (ARUK-PG2012-8)